- Home
- LCFY vs HOTH Comparison
LCFY vs HOTH Comparison
Compare LCFY & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- HOTH
- Stock Information
- Founded
- LCFY 2009
- HOTH 2017
- Country
- LCFY Australia
- HOTH United States
- Employees
- LCFY N/A
- HOTH 3
- Industry
- LCFY
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- HOTH Health Care
- Exchange
- LCFY Nasdaq
- HOTH Nasdaq
- Market Cap
- LCFY 3.7M
- HOTH 16.0M
- IPO Year
- LCFY 2022
- HOTH 2019
- Fundamental
- Price
- LCFY $4.50
- HOTH $1.44
- Analyst Decision
- LCFY
- HOTH Strong Buy
- Analyst Count
- LCFY 0
- HOTH 3
- Target Price
- LCFY N/A
- HOTH $4.00
- AVG Volume (30 Days)
- LCFY 5.0M
- HOTH 733.2K
- Earning Date
- LCFY 07-22-2025
- HOTH 05-12-2025
- Dividend Yield
- LCFY N/A
- HOTH N/A
- EPS Growth
- LCFY N/A
- HOTH N/A
- EPS
- LCFY N/A
- HOTH N/A
- Revenue
- LCFY $2,668,385.00
- HOTH N/A
- Revenue This Year
- LCFY N/A
- HOTH N/A
- Revenue Next Year
- LCFY N/A
- HOTH N/A
- P/E Ratio
- LCFY N/A
- HOTH N/A
- Revenue Growth
- LCFY N/A
- HOTH N/A
- 52 Week Low
- LCFY $2.50
- HOTH $0.58
- 52 Week High
- LCFY $13.98
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- LCFY 52.74
- HOTH 62.68
- Support Level
- LCFY $4.28
- HOTH $1.17
- Resistance Level
- LCFY $5.40
- HOTH $1.34
- Average True Range (ATR)
- LCFY 1.17
- HOTH 0.10
- MACD
- LCFY 0.08
- HOTH 0.02
- Stochastic Oscillator
- LCFY 20.23
- HOTH 77.27
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).